Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:862 (16 April), doi:10.1136/bmj.330.7496.862
| The first 150 words of the full text of this article appear below. |
Cheap, fixed dose treatment is planned for malaria: The Drugs for Neglected Diseases Initiative (a non-profit drug development organisation) and Sanofi-Aventis have agreed to develop a new, fixed dose combination of artemisinin based compound to treat falciparum malaria in Africa. The target price of the treatment is less than $1 (£0.53;
0.77) for a three day course.
US doctors rebuff drug watchdog group: The American College of Physicians has refused to allow the non-profit US organisation No Free Lunch, a group devoted to reducing competing interests in medicine, to rent a booth at its annual meeting. The college said the presence of the group would inhibit dialogue between industry exhibitors and doctors.
UK government to sponsor research into gel against HIV: The UK government will provide £24m ($45m;
35m) to fund a Medical Research Council trial assessing a microbicide gel aimed at preventing HIV infection in women, particularly those who
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses